BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1653314)

  • 1. Diagnosis and treatment of oral candidosis.
    Lewis MA; Samaranyake LP; Lamey PJ
    J Oral Maxillofac Surg; 1991 Sep; 49(9):996-1002. PubMed ID: 1653314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
    Smith DE; Midgley J; Allan M; Connolly GM; Gazzard BG
    AIDS; 1991 Nov; 5(11):1367-71. PubMed ID: 1662959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral candidosis in HIV-infected patients.
    Gazzard BG; Smith D
    Br J Clin Pract Suppl; 1990 Sep; 71():103-8. PubMed ID: 2091730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of oral candidosis with itraconazole: a review.
    Blatchford NR
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):565-7. PubMed ID: 2170476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient therapy of HIV-associated oral and oesophageal candidosis.
    Ustianowski AP; Leake H; Evans S
    Int J STD AIDS; 1997 Sep; 8(9):592-4. PubMed ID: 9292351
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole.
    Hay RJ; Clayton YM
    Rev Infect Dis; 1987; 9 Suppl 1():S114-8. PubMed ID: 3027834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of oropharyngeal candidiasis in HIV-positive patients.
    Greenspan D
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S51-5. PubMed ID: 7915732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
    Koks CH; Meenhorst PL; Bult A; Beijnen JH
    Pharmacol Res; 2002 Aug; 46(2):195-201. PubMed ID: 12220961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-NĂ¼bling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P; Arendorf TM
    Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole and itraconazole for vulvo-vaginal candidosis.
    Drug Ther Bull; 1990 Jan; 28(2):7-8. PubMed ID: 1966679
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies.
    Lalla RV; Patton LL; Dongari-Bagtzoglou A
    J Calif Dent Assoc; 2013 Apr; 41(4):263-8. PubMed ID: 23705242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral candidal infections and antimycotics.
    Ellepola AN; Samaranayake LP
    Crit Rev Oral Biol Med; 2000; 11(2):172-98. PubMed ID: 12002814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN; Samaranayake LP
    Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of oral lesions of HIV infection. 1. Candidosis.
    Scully C; Epstein JB; Porter S; Luker J
    Br Dent J; 1990 Nov; 169(9):295-6. PubMed ID: 2261280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.